rapid tuberculosis test / for genetic mutations / Mycobacterium tuberculosis / molecular
tuberculosis, for genetic mutations
Two-hour detection of MTB and rifampin-resistance mutations
Current MTB diagnostics methods require weeks to deliver a definitive result. Delayed result reporting can lead to patients being left untreated or placed on ineffective therapies. If untreated, patients may continue to spread MTB to others in the community increasing the disease burden.
Great challenges face the global community, including United States, with the worldwide re-emergence of TB and increased number of multi-drug resistant (MDR) and emergence of extensively drug-resistant (XDR) TB strains. The need for fast and accurate TB diagnosis with indication for the drug resistance is greater than ever.
Xpert MTB/RIF, on-demand molecular testing — an ideal solution:
Unprecedented sensitivity for detecting MTB — even in smear-negative, culture-positive specimens
Simultaneous detection of both MTB and rifampin resistance mutations, which are markers for MDR strain
On-demand capability that empowers physicians to manage patients effectively
Excellent Negative Predictive Value keeps TB negative patients from unnecessary and costly respiratory isolations